PT3246013T - Inibição da adesão de microrganismos patogénicos por um estearato de sacarose e/ou de sorbitano no tratamento cosmético da atopia cutânea - Google Patents

Inibição da adesão de microrganismos patogénicos por um estearato de sacarose e/ou de sorbitano no tratamento cosmético da atopia cutânea

Info

Publication number
PT3246013T
PT3246013T PT171808462T PT17180846T PT3246013T PT 3246013 T PT3246013 T PT 3246013T PT 171808462 T PT171808462 T PT 171808462T PT 17180846 T PT17180846 T PT 17180846T PT 3246013 T PT3246013 T PT 3246013T
Authority
PT
Portugal
Prior art keywords
patogenic
polysorbate
microorganisms
inhibition
adhesion
Prior art date
Application number
PT171808462T
Other languages
English (en)
Inventor
Thorel Jean-Noël
Gatto Hugues
Original Assignee
Thorel Jean Noel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thorel Jean Noel filed Critical Thorel Jean Noel
Publication of PT3246013T publication Critical patent/PT3246013T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Biomedical Technology (AREA)
PT171808462T 2012-08-07 2013-07-31 Inibição da adesão de microrganismos patogénicos por um estearato de sacarose e/ou de sorbitano no tratamento cosmético da atopia cutânea PT3246013T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1257681A FR2994386B1 (fr) 2012-08-07 2012-08-07 Inhibition de l'adhesion de micro-organismes pathogenes par un ester de saccharose et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee

Publications (1)

Publication Number Publication Date
PT3246013T true PT3246013T (pt) 2019-10-29

Family

ID=47022892

Family Applications (1)

Application Number Title Priority Date Filing Date
PT171808462T PT3246013T (pt) 2012-08-07 2013-07-31 Inibição da adesão de microrganismos patogénicos por um estearato de sacarose e/ou de sorbitano no tratamento cosmético da atopia cutânea

Country Status (9)

Country Link
EP (2) EP2882413B1 (pt)
JP (2) JP6352261B2 (pt)
KR (1) KR102059919B1 (pt)
CN (1) CN104602668B (pt)
CA (1) CA2881267C (pt)
ES (2) ES2668302T3 (pt)
FR (1) FR2994386B1 (pt)
PT (1) PT3246013T (pt)
WO (1) WO2014023895A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2897250B2 (ja) 1989-04-28 1999-05-31 スズキ株式会社 デファレンシャル装置
BR112018072236A2 (pt) 2016-05-26 2019-02-12 Kimberly Clark Co método de inibir micróbios de se ligarem a uma superfície, composição antiaderente para impedir a ligação de micróbios a uma superfície, e, lenço para inibir a fixação de micróbios a uma superfície.
FR3065372B1 (fr) * 2017-04-21 2019-12-20 Jean Noel Thorel Composition comprenant de la carboxy methyl naringenine chalcone pour le traitement du prurit et de la dermatite atopique
CN108524478B (zh) * 2018-06-11 2020-05-08 四川昇嘉科技有限公司 山椒素在制备修复皮肤光损伤的外用制剂中的用途
MX2021013853A (es) * 2019-05-16 2022-01-07 Unilever Ip Holdings B V Uso de un azucar o alcohol de azucar.
CN113509457B (zh) * 2020-09-07 2023-03-21 四川昇嘉科技有限公司 山椒素在制备治疗湿疹的药物中的用途
KR20220083289A (ko) 2020-12-11 2022-06-20 정기순 음주운전 방지시스템
FR3118416B1 (fr) 2020-12-24 2023-11-17 Naos Inst Of Life Science Composition cosmetique apte a renforcer les jonctions serrees epidermiques pour la prevention et/ou le traitement de la dermatite atopique
WO2022230925A1 (ja) * 2021-04-28 2022-11-03 アスパック企業株式会社 膿皮症改善剤
EP4548910A3 (en) * 2024-12-19 2025-07-16 Clariant International Ltd Compounds for use on mucosal tissue

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01311014A (ja) * 1988-06-06 1989-12-15 Taiyo Kagaku Co Ltd 抗菌性皮膚外用剤
NL1003524C2 (nl) * 1996-07-05 1998-01-12 Cooperatie Cosun U A Luieruitslagpreventie- c.q. -behandelingssamenstelling.
US5961997A (en) * 1997-03-25 1999-10-05 Swinehart; James M. Antipruritic composition
DE19718777A1 (de) * 1997-05-03 1998-11-05 Beiersdorf Ag Verwendung von Estern aus Fettsäuren und Di- und Oligosacchariden gegen die Adhäsion von Mikroorganismen
FR2798591B1 (fr) * 1999-09-22 2001-10-26 Pharmascience Lab Utilisation d'un produit d'huile vegetale pour augmenter la synthese des lipides cutanes en cosmetique, pharmacie ou dermatologie et en tant qu'additif alimentaire
JP2001181175A (ja) * 1999-12-27 2001-07-03 Prosper & Company Kk 化粧品及び医薬部外品
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
JP2003012492A (ja) * 2001-07-02 2003-01-15 Noevir Co Ltd 化粧料
JP2003089660A (ja) * 2001-09-18 2003-03-28 Mitsubishi-Kagaku Foods Corp 外用剤の変質防止方法
EP1340486A1 (de) * 2002-03-01 2003-09-03 Cognis France S.A. Verwendung von Zuckerestern
JP4509517B2 (ja) * 2002-09-19 2010-07-21 ロート製薬株式会社 黄色ブドウ球菌の皮膚付着を阻害し、かつ、表皮ブドウ球菌の皮膚付着を促進させる剤
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
ES2532906T5 (es) * 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
TWI365075B (en) * 2004-09-22 2012-06-01 Kao Corp Microemulsion
WO2006134937A1 (ja) * 2005-06-14 2006-12-21 Sekisui Chemical Co., Ltd. 皮膚外用剤
JP2007332055A (ja) * 2006-06-13 2007-12-27 Sekisui Chem Co Ltd 皮膚外用剤
CN101468006B (zh) * 2007-12-25 2011-12-28 重庆华邦制药股份有限公司 含有多塞平和烟酰胺的复方药物组合物
WO2009128584A1 (en) * 2008-04-14 2009-10-22 C.A. Pharm Co., Ltd. The composition for the prevention and treatment of striae distensae and atopy
KR20090108848A (ko) * 2008-04-14 2009-10-19 주식회사 씨에이팜 아토피 치료용 조성물
US20100080768A1 (en) * 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
DE602008005497D1 (de) * 2008-12-23 2011-04-21 Intendis Gmbh Schäumbare Zusammensetzung, die im Wesentlichen frei von pharmazeutisch aktiven Inhaltsstoffen ist, zur Behandlung der menschlichen Haut
DE102009022444A1 (de) * 2009-05-23 2010-01-07 Clariant International Limited Zusammensetzung enthaltend Sorbitanmonocaprylat und antimikrobielle Wirkstoffe
JP5594868B2 (ja) * 2010-01-25 2014-09-24 株式会社ミルボン 整髪剤組成物
FR2970177B1 (fr) * 2011-01-11 2013-08-02 Oreal Composition huileuse demaquillante

Also Published As

Publication number Publication date
KR20150040909A (ko) 2015-04-15
EP3246013A1 (fr) 2017-11-22
JP2018030852A (ja) 2018-03-01
EP2882413B1 (fr) 2018-04-11
HK1206975A1 (en) 2016-01-22
EP2882413A2 (fr) 2015-06-17
WO2014023895A2 (fr) 2014-02-13
CA2881267A1 (en) 2014-02-13
WO2014023895A3 (fr) 2014-05-01
CA2881267C (en) 2021-02-16
ES2751878T3 (es) 2020-04-02
JP6408667B2 (ja) 2018-10-17
FR2994386A1 (fr) 2014-02-14
JP6352261B2 (ja) 2018-07-04
CN104602668A (zh) 2015-05-06
FR2994386B1 (fr) 2016-06-24
ES2668302T3 (es) 2018-05-17
EP3246013B1 (fr) 2019-10-09
KR102059919B1 (ko) 2019-12-27
CN104602668B (zh) 2018-12-28
JP2015528822A (ja) 2015-10-01

Similar Documents

Publication Publication Date Title
PL2704704T3 (pl) Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry
GB2478595B (en) Phytocannabinoids in the treatment of glioma
IL225239A0 (en) Compounds for the treatment of acne and related diseases
GB2509617B (en) Dishwasher and method of controlling the same
SG10201608870UA (en) Nanostructured articles and methods to make the same
SI2855687T1 (sl) Mikroorganizmi in metode za proizvodnjo 4-hidroksibutirat, 1,4-butandiola in sorodne spojine
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
ZA201404676B (en) Compositions and methods for treating metabolic disorders
EP2652141A4 (en) MICROORGANISMS AND METHOD FOR PRODUCING 1,4-CYCLOHEXANDIMETHANOL
GB201218831D0 (en) Permenter and the method of fermentation
ZA201408055B (en) Compositions and methods for the treatment of local pain
SG2013081724A (en) Sensor and method of controlling the same
PL2726470T3 (pl) Pochodne 1,2,4-tiadiazol-5-ilo piperazyny przydatne w leczeniu chorób neurodegeneracyjnych
SI2575971T1 (sl) Kombinirani rastlinski izvlečki za uporabo pri zdravljenju okužb z mikrobi
WO2012021287A9 (en) Methods for the treatment and prevention of metabolic disorders
ZA201409017B (en) Water clarification composition and process
IL234616A0 (en) A herbal preparation for the treatment of metabolic diseases
PL2744601T3 (pl) Sposób i instalacja do obróbki przedmiotów
IL239292A0 (en) Use of fidotimide to treat atopic dermatitis
IL233354A (en) 2, 6-Dihlo-5-Alkoxy-4-Converted-Pyrimidine, Pyrimidine-Carbaldehyde and Production and Use Methods
EP2736517A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
AU2012900748A0 (en) Water treatment product and method
AU345283S (en) Shower tray
AU2012900286A0 (en) "Methods of treatment or prophylaxis"